Plasma therapy isn't proven treatment for COVID-19: Govt

The plasma therapy for treatment of coronavirus patients is at an experimental stage and it has the potential to cause life-threatening complications, the Union health ministry said on Tuesday,......

Why 'Swastha Bharat' needs the e-health push

The low priority accorded to health care in India has resulted in a vicious cycle of disease, death and destitution. Over 63 million Indians slip into poverty every year as high health care costs......

NSE to include Adani Wilmar, Adani Power to few indices from Mar 31

Leading stock exchange NSE has tweaked the constituents of its major indices with Adani Group's two companies -- Adani Wilmar and Adani Power -- all set to make their way into some of the Nifty......

Jt drugs controller waives trial of Biocon drug; arrested

The CBI has arrested Joint Drugs Controller S Eswara Reddy for allegedly receiving a Rs 4 lakh bribe to waive the phase three clinical trial of the Insulin Aspart injection, a product of Biocon......

Agnipath has large job potential: India Inc

Industry leaders, including Mahindra Group chairman Anand Mahindra, RPG Enterprises chairman Harsh Goenka and Biocon Ltd chairperson Kiran Mazumdar-Shaw on Monday came out in support of the......

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.......